Building the future of exosome medicine—together. Reach out to discuss partnerships, careers, or media inquiries.
P.S.K Biosciences is developing next-generation exosome platforms for RNA delivery, CNS and extrahepatic targeting, inflammation modulation, and tissue regeneration. We welcome strategic collaborations with pharmaceutical companies, biotech innovators, academic institutions, clinical centers, and regional development partners.
Our team will get back to you within 2 business days.